Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$8.18 USD
-0.60 (-6.83%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $8.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.43 | 0.00% |
Earnings Summary
For their last quarter, Verrica Pharmaceuticals (VRCA) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.54 per share. This reflects a positive earnings surprise of 29.63%. Look out for VRCA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.43 per share, reflecting a year-over-year decrease of 104.76%.
Earnings History
Price & Consensus
Zacks News for VRCA
Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
VRCA: What are Zacks experts saying now?
Zacks Private Portfolio Services